Our data suggest that upregulation of Lin28b, which plays a broader role in lipid metabolism, supports the pathogenesis of Rpl22-deficient MLL-AF9 transgenic AML through induction of TG synthesis. The gene discussed is MLLT3; the disease is acute myeloid leukemia.